Amneal Pharmaceuticals, Inc.: Ranitidine Tablets, USP 300 mg, 250-count
Recall reason: CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API. Recalled by Amneal Pharmaceuticals, Inc.. Distribution: Product was distributed throughout the United States.. Classification (Class II — potential health risk). Affected lots/NDC/dates: HB04118A 2/2020 HB04218A 2/2020 HB04318A 2/2020 HB04418A 2/2020 HF13518A 6/2020 HF13618A 6/2020 HF13718A 6/2020 H. Return the recalled medication to the pharmacy where you purchased it for a full refund of the purchase price.
📬 Get email alerts for new Product Recalls & Refunds
Free — we'll email you when new matching opportunities appear. No spam, unsubscribe anytime.
New here? Here's how Reward Opportunity works:
🔔 More Product Recalls & Refunds
Product recalls offering refunds, replacements, or repairs to consumers who purchased the item.
Browse all product recalls & refunds →Not just this one — find everything you qualify for
Our AI scans 8,000+ bounties, settlements, grants, recalls, and paid studies against your profile to rank what you can actually claim.
Get My Free Match Report